These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11825009)

  • 1. Invasive infections due to vancomycin-resistant enterococci in adult patients.
    Jean SS; Fang CT; Wang HK; Hsue PR; Chang SC; Luh KT
    J Microbiol Immunol Infect; 2001 Dec; 34(4):281-6. PubMed ID: 11825009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual increase of vancomycin-resistant Enterococcus faecium but not Enterococcus faecalis at a university hospital in Taiwan.
    Chiang PC; Wu TL; Su JY; Huang YC; Chiu YP; Chia JH; Kuo AJ; Su LH
    Chang Gung Med J; 2007; 30(6):493-503. PubMed ID: 18350732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
    Hagman HM; Strausbaugh LJ
    Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bloodstream infections with vancomycin-resistant enterococci.
    Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
    Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
    Marron A; Carratalà J; Ayats J; Fernández de Sevilla A; Domínguez MA; Liñares J; Gudiol F
    Med Clin (Barc); 1998 Dec; 111(20):761-4. PubMed ID: 9922964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
    Scheetz MH; Qi C; Noskin GA; Warren JR; Postelnick MJ; Malczynski M; Huang J; Zembower TR
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):407-13. PubMed ID: 16930924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
    Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
    Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vancomycin-resistant enterococci: ONERBA networks data and results of the national 2006 survey on digestive carriage].
    Fortineau N; Leclercq R; Maugat S; Robert J;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S65-7. PubMed ID: 18598874
    [No Abstract]   [Full Text] [Related]  

  • 12. Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization.
    Noskin GA; Cooper I; Peterson LR
    Arch Intern Med; 1995 Jul; 155(13):1445-7. PubMed ID: 7794095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vancomycin-resistant Enterococcus faecium infections.
    Lai KK
    Arch Intern Med; 1996 Dec 9-23; 156(22):2579-84. PubMed ID: 8951301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging vancomycin resistance in enterococci in India.
    Ghoshal U; Garg A; Tiwari DP; Ayyagari A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):620-2. PubMed ID: 17183879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.
    Lietzau S; Hoewner M; von Baum H; Marre R; Brenner H
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):275-7. PubMed ID: 16287198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
    Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
    Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
    Klare I; Witte W
    Wien Klin Wochenschr; 1997 May; 109(9):293-300. PubMed ID: 9265387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.